Brind.

Dexcom, Roche, and Exact Sciences were cited as industry leaders innovating aggressively in POC solutions.

1 report, 1 independent Updated Jul 30

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Dexcom Hoffmann-La Roche Exact Sciences

Keep exploring

The entities involved

Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
- Tandem Mobi utilizes Dexcom G7 technology for monitoring.Mon 09:18
- Oura announces partnerships with Dexcom and Resmed for health feature integration, while noting that regulatory uncertainty affects its product scope.Wed 08:52
Hoffmann-La Roche
Swiss healthcare company
- Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44
- Hoffmann-La Roche opened a new R&D center in Boston.Sat 11:08
Exact Sciences
American company in Madison, United States
- Zacks Investment Research provided stock analysis and ratings for Exact Sciences.Sun 06:59

Coverage

Newest first; wire copies grouped

Jul 30PR NewswireRapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report ARLINGTON, Va., July 29, 2025 /PRNewswire/ -- A new report from Kalorama Information